Idinvest Partners Mergers & Acquisitions

Idinvest Partners M&A Summary

The Firm’s most common exit type is trade sale (48%). Idinvest Partners’ largest (disclosed) exit occurred in 2011 when it sold Converteam SAS for $3.2B.

Sign-up to view Idinvest Partners’ full profile and discover more mega-sized private equity firm investors just like it.

M&A Summary

  • M&A Total Activity116
    • M&A Buy Activity78
    • M&A Sell Activity38
  • M&A Buy/Sell Connections36

Idinvest Partners

117, avenue des Champs-Élysées,
Paris, 75008
France
+33 (0)1 58 18 56 56
www.idinvest.com

All (116) Buy (78) Sell (38)
Date Target Value
$mlns
Transaction Type Acquirer Seller SRC
Link
2021-11-05 IO Biotech · Life Science
Copenhagen, Denmark · www.iobiotech.com

IO Biotech is a clinical stage biotech company developing disruptive immune therapies for the treatment of cancer. IO Biotech's pipeline of first-in-class immune modulating anti-cancer therapies is based on a unique platform technology enabling the activation of T cells that are specific for immune inhibitory molecules. IO Biotech was founded in 2014 and is based in Copenhagen, Denmark.

- IPO -

HBM Partners PE

Idinvest Partners PE

Vivo Capital PE

-

Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.